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Xenoestrogens are chemical compounds
released in the environment that mimic the
action of natural estrogens. Although their
chemical structure is different from that of
estradiol, these compounds can bind the
estrogen receptor and activate the transcrip-
tion ofits target genes. Environmental estro-
gens were suspected to play a role in decreas-
ing the quantity and quality ofhuman semen
during the last 50 years (1,2) and in increas-
ing the incidences ofcryptorchidism (3-5)
and testicular cancer (6-8) in men and breast
cancer in women (9 in industrialized coun-
tries, at least in some studies. The deleterious
action ofendocrine disruptors was observed
inwildlife; for example, the decreased fertility
of alligators and turtles in Lake Apopka,
Florida, could be due to a spill of the pesti-
cide Kelthane (10). Thus, it is important to
develop appropriate tests to assess the estro-
genicactivityofsyntheteticcompounds.
The target receptor of xenoestrogens is
the estrogen receptor (ER), a member ofthe
nudear receptors superfamily. Nudear recep-
tors mediate the cellular actions of several
hormones and effectors such as steroid hor-
mones, triiodothyronine (T3), retinoic acid,
and vitamin D (11). There are two large
families ofligand-activated nudear receptors:
the glucocorticoid receptor family and the
estrogen/thyroid hormone receptor family
(12,13). Most of the receptors of the latter
family bind DNA as heterodimers with the
retinoid X receptor. Their responsive ele-
ments generally consist of direct repeats of
the AGGTCA half-site (14). Interestingly,
the estrogen responsive element (ERE) is
different in that it is usually palindromic
and consists of inverted half-sites separated
by three base pairs (15). In the case of the
ER, following hormonal stimulation, the
ER binds to an ERE as a homodimer, thus
modulatinggene expression (16-1M.
We have previously described the inter-
action oftwo dimers ofthe estrogen receptor
with an overlapping ERE (overERE), which
consists of two EREs separated by five base
pairs (center to center) (20). We have shown
that such an overERE sequence is functional
and cooperatively binds a tetramer of ER.
Furthermore, the two overEREs display a
synergistic transcriptional activation. Thus,
binding oftwo ER dimers on opposite sides
of the DNA double helix enhances their
transcriptional efficacy.
In this report we have used this con-
struct to perform a detection assay of the
estrogenic activity ofchemical compounds.
In transfection experiments, estradiol acti-
vated transcription from an overERE con-
taining promoter four to six times better
than from a single ERE containing pro-
moter. This synergestic effect was observed
using either the natural hormone (17,-
estradiol) or organochlorine xenoestrogens,
and improved the detection of these com-
pounds by at least one order ofmagnitude.
Materials and Methods
Cellculure. The human hepatoma cell line
HepG2 (21) was cultured in Dulbecco's
Modified Eagle Medium (DMEM) without
phenol red and supplemented with 10%
fetal calfserum (Gibco, Grand Island, NY),
100 U/ml penicillin and 100 pl/ml strepto-
mycin (Diamant, Puteaux, France), and 0.5
pg/ml flngizone (Squibb, Princeton, NJ).
Chemicals. 171-Estradiol, DDT, and
isophorone were purchased from Sigma
Aldrich (Saint Quentin, France), and
Gesaprim, Madit, Illoxan, and Betanal were
from AgreVo (Paris, France). Toxaphene,
dieldrin, and endosulfan were purchased
from Supelco (Bellofonte, PA).
Plmid. The plasmid AMTV-CAT was
derived from the plasmid MMTV-CAT by
deletion ofthe sequence from position -190
to -88 of the mouse mammary tumor virus
long terminal repeat (24. A HindIII site, cre-
ated at the deletion site, was used as acloning
site forall oligonucleotides used in this study.
These oligonucleotides were also subcloned
into the HindIII site oftheTk-CAT plasmid.
The double stranded oligomers (ERE and
overERE) have 5' extensions that are com-
patible with a HindIII site. However, the
restriction site is lost in the recombinant plas-
mid. The sequence ofERE is as follows, with
ERE sites underlined: strand A, 5'AGCT-
GCTCAGCT AGGTCA CTG CGACCT
CTACT3'; strand B, 5'AGCTAGTAG
AGGGCT GAG TGACCT AGCT-
GAGC3'. The sequence of overERE is as
follows: strand A, 5'AGCTGCTCAGCT
AGGTCAGGTCGACCTGACCT
CTACT3'; strand B, 5'AGCTAGTAG
AGGTCAGGTCGACCT GACCTAGCT-
GAGC3' (ERE sites are underlined). The
luciferase plasmid (RSV-Luc) was purchased
from Promega (Madison, WI).
Transfection experiments. Transfection
experiments were performed as described by
Massaad et al. (23). One daybefore the trans-
fection, HepG2 cells (106 cells/10-cm dish)
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were seeded into phenol red-free DMEM
containing 10% fetal calfserum. Ten milli-
liters of fresh medium with 10% charcoal-
treated serum was added to the cells 2-3 hr
before the transfection. The serum was
treated as follows: 100 ml offetal calfserum
was incubated with 1 g ofNorit A activated
charcoal (Sigma Aldrich) and 0.1 g ofdex-
tran T70 (Pharmacia Biotech, Uppsala,
Sweden) and heated at 56°C for 30 min.
This procedure was repeated twice and the
mixture was filtered through a 0.22-pm
membrane. The chloramphenicol acetyl-
transferase (CAT) plasmids (5 pg ofDNA),
the human ER (hER) expression vector (5
ng and 5 jg), and the luciferase expression
vector (1 pg) were introduced into the cells
by the calcium phosphate coprecipitation
technique (23) followed byaglycerol shock.
Following the glycerol shock, 10 ml offresh
medium containing 5% charcoal-treated
serum was added to the cells. Sixteen hours
later, serum-free medium was added and
cells were treated with reference hormone
or pesticides. After an additional 24-hr
incubation, cells were homogenized for
CAT andluciferase assays.
Luciferase assay. We used luciferase
activity to normalize the transfection effi-
ciency in all culture dishes (24). The
luciferase assay was performed using a
luciferase assay system kit from Promega
and the manufacturer's instructions. Briefly,
the transfected cells were washed twice with
5 ml calcium- and magnesium-free phos-
phate-buffered saline (PBS) andlysed in 500
jl of Reporter Lysis Buffer IX (Promega)
for 15 min. After a 5-min centrifugation, 20
pl ofthe supernatant was mixedwith 100 jil
of luciferase assay reagent (Promega) at
room temperature. The luciferase activity
was measured using a luminometer 30 sec
afteraddition ofthe assayreagent.
CATassay. The CAT activitywas deter-
mined using the two-phase assay developed
by Neumann et al. (25). Briefly, 60 pl of
cellular extract, heated at 65°C for 10 min,
was incubated with 1 mM chlorampheni-
col, 30 p1 acetyl CoA, and 0.5 pCi [3H]-
acetyl CoA (NET-290 L, NEN) at 37°C
for 30 min. The solution was then trans-
ferred to a minivial and layered with 4 ml
ofEconofluor(NEF 969, NEN). After vig-
orous mixing, the two phases were allowed
to separate for at least 15 min, and the
radioactivitywas then counted in ascintilla-
tion counter. Under these conditions, the
product ofthe reaction, acetylated chloram-
phenicol, but not unreacted acetyl-CoA,
can diffuse into the Econofluor phase. For
these experiments, blanks were obtained by
assaying CAT activity in cells that had
undergone the same treatment in the
absence ofa CAT plasmid.
Statistics. Statistical analyses ofthe data
were performed using the Mann Whitney
Utest.
Results
We designed a novel sequence (overERE)
formed oftwo overlapping ERE sequences.
This was possible because a classical ERE
consists oftwo half-sites separated by three
base pairs. We selected these nucleotides
and adjacent nucleotides in order to design
two overlapping identical EREs. This
sequence binds cooperatively two dimers of
ER on the opposite sides ofthe DNA dou-
ble helix and could elicit transcriptional
activation by estrogens (20).
To compare the efficiency of transcrip-
tional activation ofa classical consensus ERE
and the overERE unit, we subdoned these
constructs in a AMTV-CAT plasmid and
made transient transfection in HepG2 cells
using these constructs and an ER expression
vector. As shown in Figure 1, 17fP-estradiol
activated both ERE and overERE constructs
at 0.01 nM, but the transcriptional activa-
tion elicited by overERE was 3- to 4-fold
higher than ERE. These results show that
two overlapping EREs elicit a synergistic
activation of transcription. The median
effective concentration (EC50) elicited by
estradiol on these two constructs were slight-
lydifferent(EC50 ofERE = 0.1 nM; EC50 of
overERE = 0.03 nM).
We compared the responsiveness of
ERE- and overERE-containing promoters
to various classes ofxenoestrogens.
ax-Endosulfan (1,4,5,6,7,7-hexachloro-
5-norbornene-2,3-dimethanol cyclic sul-
fite), a well known insecticide that mimics
estrogen activity (26), was added at differ-
ent concentrations (Figure 2). The tran-
scriptional activation elicited by the
overERE sequence was 3- to 4-fold higher
than that elicited by the ERE sequence at
the same concentration ofendosulfan. As a
consequence, when using the ERE con-
struct, we were able to detect the estrogenic
effect of endosulfan at a concentration of
10-5 M, whereas the overERE sequence
allowed us to detect a significant estrogenic
activity ofendosulfan at a lower concentra-
tion (10-6M).
We also assayed the estrogenic activity
of toxaphene, another insecticide (26).
Toxaphene is a mixture containing poly-
chloro bicyclic terpenes, with chlorinated
camphene predominating. The transcrip-
tional activation of the overERE construct
by toxaphene was more potent than that of
the ERE construct (Figure 3).
In the case of dieldrin (1,2,3,4,10,10-
hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-
octahydro-endo,exo-1,4:5,8-dimethano-
naphthalene) (26), an insecticide used for
400
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Figure 1. Functionality of the overERE construct.
Abbreviations: CAT, chioramphenicol acetyltrans-
ferase; E2, 17j3-estradiol; ER, estrogen receptor;
MWV, mammary tumorvirus; overERE,overlapping
estrogen responsive element; SE, standard error.
(A) Human hepatoma HepG2 cells were transient-
ly transfected with either the AMTV-ERE-CAT or
the AMTV-overERE-CAT plasmid and the ER
expression vector. Increasing concentrations of
were added and CAT activity was assayed.
Results were calculated as a percent ofthe maxi-
mal activity of the ERE construct (10O6 M E2) and
are expressed as the mean ± SE of four indepen-
dent experiments. (B) For each curve, results are
expressed as the percent ofthe maximal acitivity
ofthe ERE or overERE constructs, respectively, at
10-6 M E2. Results shown are the mean ± SE of
four independentexperiments.
lice and louse flies on sheep, overERE was
5- to 6-fold more potent in activating tran-
scription than ERE at a 10-6 M concentra-
tion and was approximately 3-fold more
potent at 10-5M (Figure 4).
These results indicate that synergistic
activation of transcription elicited by the
overERE sequence was observed for both
the natural hormone and for organochlo-
rine chemicals with estrogenic activity.
Moreover, the overERE was able to reveal
the estrogenic activity of compounds at
concentrations 10-fold lower than ERE.
We then screened the estrogenic activity
ofcommonly used compounds byusing the
assay described above. We incubated the
HepG2 cells, transfected by either ERE-
CAT or overERE-CAT plamids, with
increasing concentrations of Illoxan (diclo-
fop methyl, 360 gIL, a herbicide used to kill
weeds in wheat fields (Figure 5). Illoxan
weakldy activated the transcription mediated
by overERE at a concentration of 1 pM;
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Figure 2. Effect of endosulfan on human hepatoma
HepG2 cells. Abbreviations: CAT, chloramphenicol
acetyltransferase; ER, estrogen receptor; MWV,
mammarytumorvirus; overERE, overlapping estro-
gen responsive element. HepG2 cells were tran-
sientlytransfected with eitherthe AMTV-ERE-CAT
or AMTV-overERE-CAT(s) plasmids and ER
expression vector. Increasing concentrations of
endosulfan were added to the culture medium.
Results are expressed as the percent ofthe maxi-
mal activity of the ERE construct (10-5 M endosul-
fan) and are means ± standard errors offive inde-
pendentexperiments.
*Significantly different (p < 0.05) from both the value of
the untreated overERE-transfected cells and from the
value ofthe ERE-transfected cells treated with the same
amount of compound.
this induction was clear at 10 pM Illoxan
(3-fold induction as compared to the activi-
ty in untreated cells). The transactivation
elicited by ERE was weak even at 100 gM.
These results show that Illoxan mimics the
estrogenic activity and can be classified as
an endocrine disruptor.
We also tested the estrogenic activity of
Betanal (phenmedipham, 157 g/L), a her-
bicide used to kill weeds in beet fields
(Figure 6). Betanal did not elicit a transac-
tivation mediated by ERE. In contrast,
Betanal dearly activated the overERE-con-
taining plasmid at 10-5 M. The estrogenic
activity ofBetanal was revealed only by the
use ofthe overERE.
To determine if some commonly used
commercial products elicit estrogenic activi-
ty, we used the detection assay described
above to test the following compounds:
Gesaprine, Madit (herbicide), Prodactif
(insecticide; AgreVo), Isophorone, and Decis
(insecticide). DDT (insecticide), a well-
known xenoestrogen, was also tested as a
positive control. Increasing concentrations of
each compound were added to HepG2 cells
transiently transfected with the overERE-
CAT plasmid and ER expression vector. In
Table 1, we have reported only the lowest
concentration of the tested compound at
which a detectable estrogenic activity was
observed. Only Gesaprine and, as expected,
DDT displayed estrogenic activity at a con-
centration of106 M. The other tested com-
pounds (Madit, Isophorone, Decis, and
Prodactif) did not elicit any detectable estro-










Figure 3. Effect of toxaphene on human hepatoma
HepG2 cells. Abbreviations: CAT, chloramphenicol
acetyltransferase; ER, estrogen receptor; MTV,
mammarytumorvirus; overERE, overlapping estro-
gen responsive element. HepG2 cells were tran-
siently transfected with either AMTV-ERE-CAT or
AMWV-overERE-CAT plasmids and ER expression
vector. Increasing concentrations of toxaphene
were added to the culture medium. Results are
expressed as the percent of the maximal activity
of the ERE construct (10-5 M toxaphene) and are
the means ± standard errors of four independent
experiments.
*Significantly different (p < 0.05) from both the value of
the untreated overERE-transfected cells and from the
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Figure 5. Effect of Illoxan on human hepatoma
HepG2 cells. Abbreviations: CAT, chlorampheni-
col acetyltransferase; ER, estrogen receptor;
MTV, mammarytumorvirus; overERE, overlapping
estrogen responsive element. HepG2 cells were
transiently transfected with either AMTV-ERE-
CAT or AMTV-overERE-CAT (s) plasmids and ER
expression vector. Increasing concentrations of
Illoxan were added tothe culture medium. Results
are expressed as the percent of the maximal
activity of the ERE construct (10 M Illoxan) and
are the means ± standard errors of four indepen-
dentexperiments.
*Significantly different (p < 0.05) from both the value of
the untreated overERE-transfected cells and from the
value ofthe ERE-transfected cells treated with the same
amount of compound.
Discussion
Humans and animals are exposed to
endogenous estrogens, phytoestrogens, and
xenoestrogens. The manufactured estrogens
have deleterious effects on wildlife (27).
Xenoestrogens have been implicated in the
decrease ofmale fertility and in the increase
ofthe incidence oftesticular and breast can-
cers in humans (28,29). To predict their
deleterious effects, various in vivo and in
vitro tests have been developed to assay
xenoestrogenic activity. In vivo tests include
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Figure 4. Effect of dieldrin on human hepatoma
HepG2 cells. Abbreviations: CAT, chlorampheni-
col acetyltransferase; ER, estrogen receptor;
MTV, mammarytumorvirus; overERE, overlapping
estrogen responsive element. HepG2 cells were
transiently transfected with either AMTV-ERE-
CAT or AMTV-overERE-CAT (s) plasmids and ER
expression vector. Increasing concentrations of
dieldrin were added to the culture medium.
Results are expressed as the percent ofthe maxi-
mal activity of the ERE construct (10-5 M dieldrin)
and are the means ± standard errors offour inde-
pendentexperiments.
*Significantly different (p < 0.05) from both the value of
the untreated overERE-transfected cells and from the
value of the ERE-transfected cells treated with the same
amount of compound.
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Figure 6. Effect of Betanal on human hepatoma
HepG2 cells. Abbreviations: CAT, chlorampheni-
col acetyltransferase; ER, estrogen receptor;
MTV, mammarytumor virus; overERE, overlapping
estrogen responsive element. HepG2 cells were
transiently transfected with either AMTV-ERE-
CAT or AMTV-overERE-CAT plasmids and ER
expression vector. Increasing concentrations of
Betanal were added to the culture medium.
Results are expressed as the percent ofthe maxi-
mal activity ofthe ERE construct (104 M Betanal)
and are the means ± standard errors offour inde-
pendent experiments.
*Significantly different (p < 0.05) from both the value of
the untreated overERE-transfected cells and from the
value ofthe ERE-transfected cells treated with the same
amountof compound.
the uterotrophic bioassay, the evaluation of
the weight of the rat uterus in response to
estrogenic activity. Another test measures
the induction of the vitellogenin gene that
is induced severalfold by estrogens in female
fish. Male fish are put in a medium con-
taining the test compound and vitellogene-
sis is then measured (30). An example ofan
in vitro assay is the E-SCREEN assay,
which measures the proliferative effect of
estrogens on their target cells (e.g., MCF-7
cells and ZK-75 cells) (31). Other bioassays
Environmental Health Perspectives * Volume 107, Number 7, July 1999
7
565Articles * Massaad and Barouki
Table 1. Estrogenic effects of various compounds
on human hepatoma HepG2 cells.
Lowest
Estrogenic concentration with
Compound activity detectable activity
Gesaprine Yes 10-6 M
Madit No -




Abbreviatons: CAT, chloramphenicol acetltransferase; ER,
estrogen receptor; MTV, mammary tumor virus; overERE,
overlapping estrogen responsive element HepG2 cellswere
transiently transfected with AMTV-overERE-CAT plasmid
and ER expression vector; increasing concentrations (10-8
M-10-5 M) ofthetestcompounds were added tothe culture
medium. The CAT activity was assayed to assess the estro-
genic activity. Only the lowest concentration at which
detectable estrogenic activity was observed is shown. Each
compound wastested infourindependentexperiments.
measure the induction of specific gene
products by estrogens [e.g. progesterone
receptor (32) and pS2 (33)]. Finally, the
transfection of recombinant yeast cell lines
(YES) by both an ER and an ERE-contain-
ing promoter is a sensitive technique to
screen xenoestrogens (34).
We have developed a method to assay
the estrogenic activity of compounds in
human cells using a reporter gene con-
trolled by an estrogen responsive unit
formed by two overlapping EREs. This
sequence synergistically activates transcrip-
tion elicited either by estradiol or xenohor-
mones. This overERE unit can detect the
estrogenic activity of compounds at lower
concentrations than can a single ERE, indi-
cating its higher sensitivity. For example,
with the overERE we were able to detect
the estrogenic activity ofIlloxan at 10 pM,
whereas we could hardly detect an increase
of transactivation with ERE at 100 pM.
Moreover, some substances that failed to
display estrogenic activity when tested with
the ERE construct elicited clear xenoestro-
genic activitywith overERE (e.g., Betanal).
The overERE assay described here pre-
sents several advantages in terms of speci-
ficity and sensitivity. As previously
described, the vitellogenin, progesterone
receptor, and pS2 genes are biomarkers
used to assay estrogenic activity of
endocrine disruptors (32,33). The promot-
ers of these genes do not only contain
EREs but they also include other transcrip-
tion factor binding sites that could be
affected by the tested compounds. Our
assay is based on the induction ofan estro-
gen responsive unit formed of EREs only.
Thus, the possible effect ofthe tested mole-
cules on other transcription factors is
avoided. More generally, in vitro assays
involving transfection methods are usually
very sensitive, but when natural promoters
are used, they may not be sufficiently spe-
cific. One advantage ofusing artificial pro-
moters is that only well-characterized
responsive elements are used-in this case,
an ERE, which decreases the risk of false
positive data.
Performing the assay with a single ERE
was not always sufficient to mediate an
induction by xenoestrogens. The synergistic
transactivation of two overlapping EREs
elicited a potent induction, allowing us to
detect smaller amounts of xenoestrogens.
Moreover, in some cases, a single ERE failed
to be activated by some compounds that
have a clear estrogenic activity (e.g.,
Betanal). Another advantage ofthe overERE
assay is that it is performed in human cells.
In conclusion, the xenoestrogen detec-
tion assay described here consists of the
transfection ofhuman cells with a reporter
gene driven by an artificial promoter. The
sensitivity ofthe assay stems from the syn-
ergistic properties of two overlapping
EREs. Its improved specificity is due to the
fact that the promoter does not contain
additional responsive elements, which is
usually the case for natural promoters. It is
possible that the assay could be further
improved using additional EREs or differ-
ent recipient cell lines.
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